Customized assay development & screening  


We understand that every target or compound is unique in its modes of action; we therefore work closely with our partners to develop and customize each assay accordingly. A focus area at Intana Bioscience is membrane proteins, for which there is only a limited number of commercially-available assays.


We recently published with our customer Merck KGaA the use of FCCS to support the identification of Methionine Aminopeptidase-2 (MetAP-2) inhibitor M8891.
https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01070


See our new publication on the quantifiaction of target occupancy in tissue:
https://doi.org/10.18632/oncotarget.22801


Check out our new GPCR-ligand interaction assay!